Key result
The high sensitivity Abbott cardiac troponin I assay demonstrated an area under the curve of 0.92 for diagnosing myocardial infarction on admission, comparable to four other assays.
Why the study?
What are the clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay for diagnosing myocardial infarction?
Observational
Yes
What are the clinical and diagnostic performance characteristics of the high sensitivity Abbott cardiac troponin I assay for diagnosing myocardial infarction?
The new high sensitivity Abbott cardiac troponin I assay demonstrates excellent analytical performance and diagnostic accuracy for myocardial infarction, comparable to existing assays.
Answers are grounded in this paper and cite their sources.
Should not yet alter troponin assay selection; extends cross-sectional evidence on hs-cTnI comparability.
OBJECTIVES: The aim of this study is to determine the imprecision profile, 99th percentile and diagnostic efficiency of a new high sensitivity cardiac troponin I (cTnI) assay. METHODS: Total imprecision was assessed by following CLSI protocol EP15-A.14. Serum pools prepared from sera of known high cardiac troponin concentrations were adjusted by dilution with serum considered to be troponin free. Determination of the 99th-percentile reference value examined a fully characterized population that had undergone non-invasive cardiac imaging. Diagnostic accuracy utilised samples from the point of care arm of the RATPAC trial (Randomised Assessment of Treatment using Panel Assay of Cardiac markers), set in the emergency departments of six hospitals. Blood samples were taken on admission and 90min from admission. Diagnosis was based on the universal definition of myocardial infarction utilising laboratory measurements of cardiac troponin performed at the participating sites together with measurements performed in a core laboratory and compared by construction of receiver operator characteristic curves. RESULTS: Total imprecision was 4%-12.1% with 10% CV of 7ng/L. cTnI was measureable in 99.5% of the samples. Troponin values were influenced by gender but not by age. The 99th percentile was 14.8ng/L (18.1 males, 8.6 females). Progressive filtering of the population reduced the 99th percentile. For the diagnosis of MI on admission the area under the curve was 0.92, statistically indistinguishable from four other assays studied (0.90-0.94). CONCLUSION: The analytical performance of the new assay meets the criteria for a high sensitivity troponin assay.
No takes yet. Share an insight, caveat, or question.
Collinson et al. (2014) conducted an observational in Myocardial infarction. High sensitivity Abbott cardiac troponin I assay vs. Four other troponin assays was evaluated on Diagnosis of myocardial infarction on admission (AUC 0.92). The high sensitivity Abbott cardiac troponin I assay demonstrated an area under the curve of 0.92 for diagnosing myocardial infarction on admission, comparable to four other assays.
Synapse has enriched 10 related papers. Consider them for comparative context: